September 14, 2021
What if a strong immune response IS A SIDE EFFECT OF INDUCING AUTOIMMUNE DISEASE?
Biologics are a class of drug that is made inside a cell. They must be kept cold. You can have an immune reaction to them. Not every biologic medication is associated with the same chance of creating antibodies. In one small study comparing three popular biologic medications, it was found that anti-drug antibodies were present in 42% of those receiving Remicade (infliximab), 33% of those receiving Humira (adalimumab), and in none of those patients receiving Enbrel (etanercept).
A review of 443 studies was done to find out how often antibodies were present in patients who had rheumatoid arthritis and were treated with biologics. This review showed that antibodies were found in 0% to 85% of patients treated with Remicade, 0% to 54% of patients treated with Humira, 21 to 52% of patients treated with Remsima (which is also marketed as Inflectra, which are both biosimilars of Remicade), 0% to 1% of patients treated with Cosentyx (secukinumab), 1 to 11% of patients treated with Stelara (ustekinumab), 0% to 13% of patients treated with Enbrel (etanercept), and 0% to 19% of patients treated with Simponi (golimumab).
So, yes, drugs can help save lives and at the same time, your body can develop antibodies against them. Of course, the purpose of a drug is to treat an illness, but an immune reaction can be a side effect, unrelated to the functioning of the therapeutic.
So, since everything in this pandemic is topsy-turvy, what if the immune response was simply a side effect of the intended purpose of the “therapeutic” what is to induce multisystemic autoimmunity?
Eight doses appear to be planned. I conclude this post with the findings of another researcher.
Animal studies show an increase in deaths from 5 doses of repeated immunization with the same antigen, and almost half of the animals die after 7 doses. – Yasufumi Murakami
What It Means to Develop Antibodies to Biologics